You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1026 to 1050 of about 5880
Next 25
07/29/2019
Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy.
Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study.
Valerie Harper to stay out of hospice care, husband says
07/26/2019
Musella Foundation Brain Tumor Copay Program has reopened!
07/20/2019
A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma
07/19/2019
Study hints at why an aggressive form of brain cancer is hard to treat
A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma)
07/18/2019
Medicare Releases Final Local Coverage Determination Providing Coverage of Optune® for Newly Diagnosed Glioblastoma
07/17/2019
ImmunoCellular Therapeutics Announces Asset Purchase Agreement with Private Biotechnology Company
Electricity helps control man’s brain tumor
07/16/2019
GBM Awareness Day This Wednesday July 17th!
Neoadjuvant Anti-PD-1 Immunotherapy Leads to Survival Benefit in Recurrent Glioblastoma
Attend an Optune Open House.
07/15/2019
Phase II study of Dovitinib in recurrent glioblastoma.
07/06/2019
Insurance type impacts the economic burden and survival of patients with newly diagnosed glioblastoma.
07/01/2019
Defeat DIPG Executive Director Jenny Mosier Speaks at FDA Public Hearing Regarding ONC201
06/25/2019
Integrating Clinical Research And Care In A Perpetual Trial
06/24/2019
Musella Foundation awards 9 grants!
06/22/2019
Medicenna Presents Preliminary Top-Line Clinical Results from their Phase 2b Trial of MDNA55 in Recurrent Glioblastoma
New Data Demonstrates Safety Profile of GammaTile Therapy for Various Brain Tumors
Bayer’s regorafenib kicks off brain cancer platform trial
06/13/2019
Webinar: Personalized Approaches to Treating Cancer Explained in Plain Language
06/12/2019
Glioblastoma Awareness Day Resolution Passes U.S. Senate with Unanimous Support
06/11/2019
Oncology Expert Keith T. Flaherty, MD Named Chairman of xCures Scientific Advisory Board
06/10/2019